现在位置:百拇书刊 >
内科学
>
血液学杂志
> 2004年.第4期
《血液学杂志》.2004年.第4期
*
A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis
*
A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine
*
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation
*
Allergen exposure–induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments
*
And a final message from antithrombin
*
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells
*
Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy
*
Anti-CD40L: biology and therapy in ITP
*
BUBR1 deficiency results in abnormal megakaryopoiesis
*
Cell adhesion: a partner for many
*
Chemokine receptor–8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion
*
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation
*
Coagulation inflammation, and apoptosis: different roles for protein S and the protein S–C4b binding protein complex
*
CXCR4 engagement is required for HIV-1–induced L-selectin shedding
*
Cyclophosphamide metabolism is affected by azole antifungals
*
Deletion of the -globin gene cluster as a cause of acquired -thalassemia in myelodysplastic syndrome
*
Dimerize and die
*
Direct killing of Epstein-Barr virus (EBV)–infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1
*
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses
*
Dual roles of the C-terminal Src kinase (Csk) during developmental vascularization
*
Dynamic regulation of Src-family kinases by CD45 in B cells
*
Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) treated w
*
Endothelial progenitor cells in infantile hemangioma
*
ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein
*
Eµ-BRD2 transgenic mice develop B-cell lymphoma and leukemia
*
Fc-RIIIa and Fc-RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia
*
Functional endothelial cells derived from rhesus monkey embryonic stem cells
*
Fungal infection in hemato-oncologic patients: better to prevent than to treat?
*
Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9
*
HFE a putative hepatocyte iron sensor?
*
High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation
*
Identification and characterization of EBP a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN f
*
Identification of a 4-base deletion in the gene in inherited intrinsic factor deficiency
*
Identification of the molecular requirements for an RAR-mediated cell cycle arrest during granulocytic differentiation
*
In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation
*
Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome
*
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
*
Localization of iron metabolism–related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes
*
LPAM (47 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease
*
Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome
*
Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and i
*
Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model
*
Platelet collagen receptors play molecular ping-pong
*
Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with
*
Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL
*
Regulation of MHC class II expression in human T-cell malignancies
*
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PET
*
Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells
*
Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia
*
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients
*
Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation platelet adhesion, and aggregation via effector pathways that do not requ
*
Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5
*
Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP
*
Swinging for the fences: persistent and efficient liver-directed gene therapy for hemophilia A
*
The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leu
*
The myelodysplastic syndromes: heterogeneneity on many levels
*
Thymosin 4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression
*
Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype
*
Transfer of allogeneic CD62L– memory T cells without graft-versus-host disease